Construction of eukaryotic expression vector and package of lentivirus vector encoding prostate cancer antigen 3
10.3969/j.issn.1007-3969.2013.11.001
- VernacularTitle:前列腺特异抗原3慢病毒表达载体的构建与包装
- Author:
Xiaojun LIU
;
Na WANG
;
Xudong YAO
;
Dalong CAO
- Publication Type:Journal Article
- Keywords:
Prostate cancer;
Prostate cancer antigen 3;
Eukaryotic expression vector;
Lentivirus
- From:China Oncology
2013;(11):857-862
- CountryChina
- Language:Chinese
-
Abstract:
Background and purpose: The increased of specific expression of prostate cancer antigen 3 (PCA3), as one of long non-coding RNA, has been observed in prostate cancer, indicating that PCA3 may contribute to the development of prostate cancer. To further study its roles in prostate cancer, we construct a lentivirus expression vector carrying the whole PCA3. Methods: PCA3 was amplified from prostate cancer cell line LNCaP by reverse transcriptase polymerase chain reaction (RT-PCR). After the sequence was proved to be correct, we recombined the pCDH-CMV-MCS-EF1-copGFP-PCA3. After transformation into E.coli cells, the candidate clones were identified by PCR amplifying, restricting enzyme digestion analysis and DNA sequencing, and the viral titer was determined. Results: Through the Blast analysis software, we compared the results of PCA3 sequence amplified by PCR with GeneBank sequence, ifnding that the homology is 99.8%. The lentivirus vector was constructed successfully, and the virus in the supernatant reached a titer of 2*108. Conclusion: The successful construction of the lentivirus vector encoding PCA3 not only lays the foundation for the further research into the effect of PCA3 gene on the prostate cancer but also provides a new therapy for advanced prostate cancer.
